Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
J Tradit Complement Med
2023 Jan 01;131:93-104. doi: 10.1016/j.jtcme.2022.10.006.
Show Gene links
Show Anatomy links
Holothuria scabra extracts confer neuroprotective effect in C. elegans model of Alzheimer's disease by attenuating amyloid-β aggregation and toxicity.
Kleawyothatis W
,
Jattujan P
,
Chumphoochai K
,
Chalorak P
,
Sobhon P
,
Meemon K
.
???displayArticle.abstract???
BACKGROUND AND AIM: Alzheimer's disease (AD) is the most common aged-related neurodegenerative disorder that is associated with the toxic amyloid-β (Aβ) aggregation in the brain. While the efficacies of available drugs against AD are still limited, natural products have been shown to possess neuroprotective potential for prevention and therapy of AD. This study aimed to investigate the neuroprotective effects of H. scabra extracts against Aβ aggregation and proteotoxicity in C. elegans model of Alzheimer's diseases.
EXPERIMENTAL PROCEDURE: Whole bodies (WB) and body wall (BW) of H. scabra were extracted and fractionated into ethyl acetate (WBEA, BWEA), butanol (WBBU, BWBU), and ethanol (BWET). Then C. elegans AD models were treated with these fractions and investigated for Aβ aggregation and polymerization, biochemical and behavioral changes, and level of oxidative stress, as well as lifespan extension.
RESULTS AND CONCLUSION: C. elegans AD model treated with H. scabra extracts, especially triterpene glycoside-rich ethyl acetate and butanol fractions, exhibited significant reduction of Aβ deposition. These H. scabra extracts also attenuated the paralysis behavior and improved the neurological defects in chemotaxis caused by Aβ aggregation. Immunoblot analysis revealed decreased level of Aβ oligomeric forms and the increased level of Aβ monomers after treatments with H. scabra extracts. In addition, H. scabra extracts reduced reactive oxygen species and increased the mean lifespan of the treated AD worms. In conclusion, this study demonstrated strong evidence of anti-Alzheimer effects by H. scabra extracts, implying that these extracts can potentially be applied as natural preventive and therapeutic agents for AD.
TAXONOMY CLASSIFICATION BY EVISE: Alzheimer's disease, Neurodegenerative disorder, Traditional medicine, Experimental model systems, Molecular biology.
Alexander,
Use of Caenorhabditis elegans as a model to study Alzheimer's disease and other neurodegenerative diseases.
2014, Pubmed
Alexander,
Use of Caenorhabditis elegans as a model to study Alzheimer's disease and other neurodegenerative diseases.
2014,
Pubmed
Alvarez,
Modeling Alzheimer's Disease in Caenorhabditis elegans.
2022,
Pubmed
Bordbar,
High-value components and bioactives from sea cucumbers for functional foods--a review.
2011,
Pubmed
,
Echinobase
Chalorak,
Holothuria scabra extracts exhibit anti-Parkinson potential in C. elegans: A model for anti-Parkinson testing.
2018,
Pubmed
,
Echinobase
Chalorak,
Diterpene glycosides from Holothuria scabra exert the α-synuclein degradation and neuroprotection against α-synuclein-Mediated neurodegeneration in C. elegans model.
2021,
Pubmed
,
Echinobase
Chen,
Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases.
2015,
Pubmed
Cohen,
Opposing activities protect against age-onset proteotoxicity.
2006,
Pubmed
Cummings,
Drug development in Alzheimer's disease: the path to 2025.
2016,
Pubmed
DanQing,
N-butanol extract of Hedyotis diffusa protects transgenic Caenorhabditis elegans from Aβ-induced toxicity.
2021,
Pubmed
Dasilva,
Amyloid-beta fibrillogenesis: structural insight and therapeutic intervention.
2010,
Pubmed
Diomede,
Oleuropein aglycone protects transgenic C. elegans strains expressing Aβ42 by reducing plaque load and motor deficit.
2013,
Pubmed
Diomede,
Tetracycline and its analogues protect Caenorhabditis elegans from β amyloid-induced toxicity by targeting oligomers.
2010,
Pubmed
Drake,
Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model.
2003,
Pubmed
Fernández-Moriano,
Evaluation of the adaptogenic potential exerted by ginsenosides Rb1 and Rg1 against oxidative stress-mediated neurotoxicity in an in vitro neuronal model.
2017,
Pubmed
Forloni,
Anti-amyloidogenic activity of tetracyclines: studies in vitro.
2001,
Pubmed
Govindan,
Phytochemicals-induced hormesis protects Caenorhabditis elegans against α-synuclein protein aggregation and stress through modulating HSF-1 and SKN-1/Nrf2 signaling pathways.
2018,
Pubmed
Griffin,
ApoE-associated modulation of neuroprotection from Aβ-mediated neurodegeneration in transgenic Caenorhabditis elegans.
2019,
Pubmed
Griñán-Ferré,
Synergistic Neuroprotective Effects of a Natural Product Mixture against AD Hallmarks and Cognitive Decline in Caenorhabditis elegans and an SAMP8 Mice Model.
2021,
Pubmed
Guo,
Systems pharmacology-based drug discovery for marine resources: an example using sea cucumber (Holothurians).
2015,
Pubmed
,
Echinobase
Hardy,
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
2002,
Pubmed
Jagota,
Effect of phenolic compounds against Aβ aggregation and Aβ-induced toxicity in transgenic C. elegans.
2012,
Pubmed
Jattujan,
Holothuria scabra extracts possess anti-oxidant activity and promote stress resistance and lifespan extension in Caenorhabditis elegans.
2018,
Pubmed
,
Echinobase
Keowkase,
Sesamin and sesamolin reduce amyloid-β toxicity in a transgenic Caenorhabditis elegans.
2018,
Pubmed
Kiew,
Jewel of the seabed: sea cucumbers as nutritional and drug candidates.
2012,
Pubmed
,
Echinobase
Kitisin,
Saponin-rich extracts from Holothuria leucospilota mediate lifespan extension and stress resistance in Caenorhabditis elegans via daf-16.
2019,
Pubmed
,
Echinobase
LaFerla,
Animal models of Alzheimer disease.
2012,
Pubmed
Leiteritz,
Amyloid-beta induced paralysis is reduced by cholecalciferol through inhibition of the steroid-signaling pathway in an Alzheimer model of Caenorhabditis elegans.
2021,
Pubmed
Link,
Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34.
2001,
Pubmed
Mitu,
Evidence for a Saponin Biosynthesis Pathway in the Body Wall of the Commercially Significant Sea Cucumber Holothuria scabra.
2017,
Pubmed
,
Echinobase
Phan,
Polyphenols Modulate Alzheimer's Amyloid Beta Aggregation in a Structure-Dependent Manner.
2019,
Pubmed
Pohanka,
Alzheimer´s disease and oxidative stress: a review.
2014,
Pubmed
Pranweerapaiboon,
An ethyl-acetate fraction of Holothuria scabra modulates inflammation in vitro through inhibiting the production of nitric oxide and pro-inflammatory cytokines via NF-κB and JNK pathways.
2020,
Pubmed
,
Echinobase
Regitz,
Resveratrol reduces amyloid-beta (Aβ₁₋₄₂)-induced paralysis through targeting proteostasis in an Alzheimer model of Caenorhabditis elegans.
2016,
Pubmed
Ruggieri,
Drugs from the sea.
1976,
Pubmed
Sangha,
Liuwei Dihuang (LWDH), a traditional Chinese medicinal formula, protects against β-amyloid toxicity in transgenic Caenorhabditis elegans.
2012,
Pubmed
Sharma,
Lower vertebrate and invertebrate models of Alzheimer's disease - A review.
2017,
Pubmed
Shinde,
Marine natural products as source of new drugs: a patent review (2015-2018).
2019,
Pubmed
Son,
Hormetic dietary phytochemicals.
2008,
Pubmed
Styren,
X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology.
2000,
Pubmed
Tangrodchanapong,
Frondoside A Attenuates Amyloid-β Proteotoxicity in Transgenic Caenorhabditis elegans by Suppressing Its Formation.
2020,
Pubmed
,
Echinobase
Tangrodchanapong,
Beneficial Effects of Cyclic Ether 2-Butoxytetrahydrofuran from Sea Cucumber Holothuria scabra against Aβ Aggregate Toxicity in Transgenic Caenorhabditis elegans and Potential Chemical Interaction.
2021,
Pubmed
,
Echinobase
Udeochu,
Microglia communication: Parallels between aging and Alzheimer's disease.
2016,
Pubmed
Wang,
Using Caenorhabditis elegans to Model Therapeutic Interventions of Neurodegenerative Diseases Targeting Microbe-Host Interactions.
2022,
Pubmed
Wang,
Aesculin offers increased resistance against oxidative stress and protective effects against Aβ-induced neurotoxicity in Caenorhabditis elegans.
2022,
Pubmed
Wolff,
Aβ42 pentamers/hexamers are the smallest detectable oligomers in solution.
2017,
Pubmed
Wu,
Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans.
2006,
Pubmed
Yang,
Otophylloside B Protects Against Aβ Toxicity in Caenorhabditis elegans Models of Alzheimer's Disease.
2017,
Pubmed
Zhang,
Shengmai Formula Ameliorates Pathological Characteristics in AD C. elegans.
2016,
Pubmed
Zhao,
Protective effect of Terminalia chebula Retz. extract against Aβ aggregation and Aβ-induced toxicity in Caenorhabditis elegans.
2021,
Pubmed
